Journal of Pharmaceutical Policy and Practice, Volume 8, Issue sup1 (2015)

Browse this journal
Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days

Journal of Pharmaceutical Policy and Practice, Volume 8, Issue sup1 (2015)

See all volumes and issues
Vol 17, 2024 Vol 16, 2023 Vol 15, 2022 Vol 14, 2021 Vol 13, 2020 Vol 12, 2019 Vol 11, 2018 Vol 10, 2017 Vol 9, 2016 Volume 8, 2015 Vol 7, 2014 Vol 6, 2013
Download citations Download PDFs

Abstracts from the 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis

Editorial

Editorial
Challenges and opportunities for pharmaceutical pricing and reimbursement policies
Sabine Vogler, Nina Zimmermann, Alessandra Ferrario, Veronika J Wirtz & Zaheer-Ud-Din Babar
Article: E1
Published online: 04 Dec 2023
First Page PreviewforChallenges and opportunities for pharmaceutical pricing and reimbursement policies | Full Text | References | PDF (498.5 KB)
  • 31 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Editorial
Policies beyond the crisis: lesson learned
Sabine Vogler, Nina Zimmermann, Veronika J Wirtz & Zaheer-Ud-Din Babar
Article: E2
Published online: 04 Dec 2023
CitationforPolicies beyond the crisis: lesson learned | Full Text | References | PDF (484.6 KB)
  • 19 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Editorial
Policy cooperation and interface issues
Sabine Vogler, Nina Zimmermann, Veronika J Wirtz & Zaheer-Ud-Din Babar
Article: E3
Published online: 04 Dec 2023
First Page PreviewforPolicy cooperation and interface issues | Full Text | References | PDF (492.5 KB)
  • 19 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Keynote Speaker Presentation

Oration
Affordable innovation: future directions in pharmaceutical policy
Suzanne R Hill
Article: K1
Published online: 04 Dec 2023
First Page PreviewforAffordable innovation: future directions in pharmaceutical policy | Full Text | References | PDF (496.8 KB)
  • 24 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Managing new premium-priced medicines in Europe
Govin Permanand & Hanne Bak Pedersen
Article: K2
Published online: 04 Dec 2023
First Page PreviewforManaging new premium-priced medicines in Europe | Full Text | References | PDF (1.1 MB)
  • 26 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Pharmaceutical pricing and reimbursement policies: perspectives for the future
Andrew L Gray
Article: K3
Published online: 04 Dec 2023
CitationforPharmaceutical pricing and reimbursement policies: perspectives for the future | Full Text | References | PDF (440.8 KB)
  • 32 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Priority medicines for Europe and the World: setting a public-health-based medicines development agenda
Veronika J Wirtz
Article: K4
Published online: 04 Dec 2023
CitationforPriority medicines for Europe and the World: setting a public-health-based medicines development agenda | Full Text | References | PDF (421.8 KB)
  • 28 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Pharmaceutical policies in Australia and New Zealand
Zaheer-Ud-Din Babar
Article: K5
Published online: 04 Dec 2023
CitationforPharmaceutical policies in Australia and New Zealand | Full Text | PDF (456.6 KB)
  • 29 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Scottish collaboration to integrate medicine therapy between out-patient and in-patient sectors
Kenneth R Paterson
Article: K6
Published online: 04 Dec 2023
CitationforScottish collaboration to integrate medicine therapy between out-patient and in-patient sectors | Full Text | PDF (421.4 KB)
  • 21 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oral Presentation

Oration
Financial based agreements and performance based agreements: the Belgian experience
Kim Pauwels, Isabelle Huys, Eveline Bielen, Sigrid Bormans, Robin Vincken, Henna Zheng, Minne Casteels & Steven Simoens
Article: O1
Published online: 04 Dec 2023
CitationforFinancial based agreements and performance based agreements: the Belgian experience | Full Text | PDF (460.5 KB)
  • 27 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
Elizabeth Docteur & Ruth Lopert
Article: O2
Published online: 04 Dec 2023
CitationforAdapting pharmaceutical reimbursement policies to manage spending on high-priced drugs | Full Text | PDF (421.9 KB)
  • 15 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure
Anna Lukačišinová & Helena Skácelová
Article: O3
Published online: 04 Dec 2023
CitationforHighly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure | Full Text | PDF (424.9 KB)
  • 24 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Impact of discounts on medicine prices
Peter Schneider & Sabine Vogler
Article: O4
Published online: 04 Dec 2023
CitationforImpact of discounts on medicine prices | Full Text | References | PDF (424.9 KB)
  • 25 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
A cost/benefit analysis of self-care initiatives in the European Union: who gains, who loses?
Anna-Theresa Renner, Julia Bobek, Herwig Ostermann, Peter Schneider & Sabine Vogler
Article: O5
Published online: 04 Dec 2023
CitationforA cost/benefit analysis of self-care initiatives in the European Union: who gains, who loses? | Full Text | PDF (460.7 KB)
  • 23 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners’ perceptions and experiences
Zaheer-Ud-Din Babar, Abdul Ali, Christine Kim, James Mcintosh, Malaika Samuel Namdas, Erica Lourdes Rodrigues, Komal Vallabh & Anne Rew
Article: O6
Published online: 04 Dec 2023
CitationforAccess to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners’ perceptions and experiences | Full Text | PDF (460 KB)
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework
Panos Kanavos & Aris Angelis
Article: O7
Published online: 04 Dec 2023
CitationforUsing Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework | Full Text | PDF (461.7 KB)
  • 18 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer
Aris Angelis & Panos Kanavos
Article: O8
Published online: 04 Dec 2023
CitationforApplying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer | Full Text | PDF (462.8 KB)
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Agnes Vitry
Article: O9
Published online: 04 Dec 2023
CitationforApproval, reimbursement and pricing of high-cost cancer medicines in Australia | Full Text | PDF (459.4 KB)
  • 20 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors
Susan Spillane, Cara Usher, Kathleen Bennett, Roisin Adams & Michael Barry
Article: O10
Published online: 04 Dec 2023
CitationforIntroduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors | Full Text | References | PDF (465.9 KB)
  • 26 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil
Yared Santa-Ana-Tellez, Veronika J Wirtz, Hubert G M Leufkens & Aukje K Mantel-Teeuwisse
Article: O11
Published online: 04 Dec 2023
CitationforPrice changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil | Full Text | PDF (464.9 KB)
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities
Sabine Vogler, August Österle & Susanne Mayer
Article: O12
Published online: 04 Dec 2023
CitationforSocioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities | Full Text | PDF (463.7 KB)
  • 26 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Why we should have more collaboration on HTA in Europe: the example of sofosbuvir
Hedi Schelleman, Rudy Dupree, Finn B Kristensen & Wim Goettsch
Article: O13
Published online: 04 Dec 2023
CitationforWhy we should have more collaboration on HTA in Europe: the example of sofosbuvir | Full Text | PDF (421.6 KB)
  • 19 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?
Nicola Magrini, Lorenzo Moja, Bernadette Cappello, Kees De Joncheere & Gilles Forte
Article: O14
Published online: 04 Dec 2023
CitationforThe 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines? | Full Text | PDF (421 KB)
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Collaborative models for increasing efficiency of early drug assessment
Anna Nachtnebel & Claudia Wild
Article: O15
Published online: 04 Dec 2023
CitationforCollaborative models for increasing efficiency of early drug assessment | Full Text | References | PDF (423.3 KB)
  • 21 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster Presentation

Oration
Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin
Jessica Fraeyman, Hans De Loof, Guido Van Hal, Guido De Meyer, Roy Remmen & Philippe Beutels
Article: P1
Published online: 04 Dec 2023
CitationforUnintended consequences of co-payment regulations in Belgium: the case of atorvastatin | Full Text | References | PDF (468.5 KB)
  • 18 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
Jaana E Martikainen, Timo Maljanen, Hanna Koskinen & Sabine Vogler
Article: P2
Published online: 04 Dec 2023
CitationforImpact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland | Full Text | References | PDF (465.9 KB)
  • 20 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Oration
Availability and prices of essential medicines for chronic diseases in older people in the Asia Pacific Region
Tuan A Nguyen, Sun Qiang, Haipeng Wang, Krishna Undela & Agnes Vitry
Article: P3
Published online: 04 Dec 2023
CitationforAvailability and prices of essential medicines for chronic diseases in older people in the Asia Pacific Region | Full Text | PDF (463.9 KB)
  • 21 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Impact of delisting OTC medicines from reimbursement list
Petra Chytilová & Robin Šebesta
Article: P4
Published online: 04 Dec 2023
CitationforImpact of delisting OTC medicines from reimbursement list | Full Text | PDF (423 KB)
  • 18 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
The impact of Ghana’s National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
Dumebi O Mordi, Kwesi Eghan & Jim Rankin
Article: P5
Published online: 04 Dec 2023
CitationforThe impact of Ghana’s National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system | Full Text | PDF (463 KB)
  • 24 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Retrospective financial analysis of medicines reimbursement services in community pharmacy
Elena Chitan
Article: P6
Published online: 04 Dec 2023
First Page PreviewforRetrospective financial analysis of medicines reimbursement services in community pharmacy | Full Text | References | PDF (887.2 KB)
  • 25 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Developing a Drug Price Reference Index in the Philippines
Manuel A Haasis, Anna M Guerrero & Marinette J Ladioray
Article: P7
Published online: 04 Dec 2023
CitationforDeveloping a Drug Price Reference Index in the Philippines | Full Text | PDF (457.6 KB)
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Policy options to deal with high-cost medicines – survey with European policy-makers
Nina Zimmermann, Sabine Vogler & Hanne Bak Pedersen
Article: P8
Published online: 04 Dec 2023
CitationforPolicy options to deal with high-cost medicines – survey with European policy-makers | Full Text | PDF (463.9 KB)
  • 25 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
A forecasting model for drug utilization and expenditure integrating a Cellular Automata model with the Budget Impact Analysis approach. Preliminary results
Roberta Joppi, Elisa Cinconze, Luca Demattè, Renato Guseo, Claudio Jommi, Cinzia Mortarino, Daniela Pase, Chiara Poggiani, Alessandro Roggeri & Daniela Roggeri
Article: P9
Published online: 04 Dec 2023
CitationforA forecasting model for drug utilization and expenditure integrating a Cellular Automata model with the Budget Impact Analysis approach. Preliminary results | Full Text | PDF (463.4 KB)
  • 28 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Availability and affordability of medicines for children
Irina Kazaryan & Lusine Vardanyan
Article: P10
Published online: 04 Dec 2023
CitationforAvailability and affordability of medicines for children | Full Text | PDF (422.2 KB)
  • 25 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Determining the prices of the medicines in the absence of superiority over alternative medical technology
Wojciech Matusewicz, Katarzyna Jagodzińska-Kalinowska, Aneta Lipińska & Maciej Pomorski
Article: P11
Published online: 04 Dec 2023
CitationforDetermining the prices of the medicines in the absence of superiority over alternative medical technology | Full Text | PDF (421.3 KB)
  • 15 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Development of pharmaceutical prices in the Republic of Macedonia in comparison to selected countries outside the national reference baskets
Kristina Hristova & Claudia Habl
Article: P12
Published online: 04 Dec 2023
CitationforDevelopment of pharmaceutical prices in the Republic of Macedonia in comparison to selected countries outside the national reference baskets | Full Text | PDF (422.8 KB)
  • 18 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?
Christine Leopold, James D Chambers & Anita K Wagner
Article: P13
Published online: 04 Dec 2023
Citationfor30 years of media coverage on high drug prices in the US – a never-ending story or a time for change? | Full Text | References | PDF (429.6 KB)
  • 15 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Cost-Containment of Non-Formulary Medicines Accessibility: Malaysian Experience
Nur Liyana Zainal Bahrin, Yahaya Hassan, Abu Bakar Abd Majeed, Nur Wahida Zulkifli & Azlan Ahmad
Article: P14
Published online: 04 Dec 2023
CitationforCost-Containment of Non-Formulary Medicines Accessibility: Malaysian Experience | Full Text | PDF (420.7 KB)
  • 20 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Value of generic medicines: an health economics study
Martin Albrecht, Ariane Höer & Anne Zimmermann
Article: P15
Published online: 04 Dec 2023
CitationforValue of generic medicines: an health economics study | Full Text | PDF (422.1 KB)
  • 23 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Prices of oncology medicines in European countries, Australia and New Zealand
Sabine Vogler, Agnes Vitry & Zaheer Ud-Bin-Babar
Article: P16
Published online: 04 Dec 2023
CitationforPrices of oncology medicines in European countries, Australia and New Zealand | Full Text | PDF (464.1 KB)
  • 23 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment
Rossen M Kazakov & Penka I Petrova
Article: P17
Published online: 04 Dec 2023
CitationforReimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment | Full Text | PDF (463.5 KB)
  • 19 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Optimising prescribing in primary care: an evaluation of financial and clinical parameters
Asal Albayati, David Lu, Liam Sergeant, Nandita Singh, Keith Crump & Zaheer-Ud-Din Babar
Article: P18
Published online: 04 Dec 2023
First Page PreviewforOptimising prescribing in primary care: an evaluation of financial and clinical parameters | Full Text | PDF (1,020.1 KB)
  • 21 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Access of high technology medicines in Russia
Liudmila Bezmelnitsyna, Dmitry Meshkov & Ramil Khabriev
Article: P19
Published online: 04 Dec 2023
CitationforAccess of high technology medicines in Russia | Full Text | References | PDF (423.9 KB)
  • 18 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
The prices outpatients have to pay for purchasing medicines in Armenia
Irina Kazaryan, Anahit Sevikyan & Margarit Melikyan
Article: P20
Published online: 04 Dec 2023
CitationforThe prices outpatients have to pay for purchasing medicines in Armenia | Full Text | PDF (423.7 KB)
  • 21 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Reimbursement measures in European countries – findings of a bibliometric literature review
Sabine Vogler, Nina Zimmermann, Antonio Olry de Labry & Jaime Espin
Article: P21
Published online: 04 Dec 2023
CitationforReimbursement measures in European countries – findings of a bibliometric literature review | Full Text | PDF (467 KB)
  • 25 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Insurance-based risk-sharing agreements
Augustin Terlinden, Amine Aissaoui & Olivier Ethgen
Article: P22
Published online: 04 Dec 2023
CitationforInsurance-based risk-sharing agreements | Full Text | References | PDF (572.5 KB)
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Pharmaceutical distribution remuneration in Europe
Sabine Vogler, Lena Lepuschütz & Peter Schneider
Article: P23
Published online: 04 Dec 2023
CitationforPharmaceutical distribution remuneration in Europe | Full Text | PDF (421.7 KB)
  • 44 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines
Aneta Lipińska, Maciej Pomorski, Wojciech Matusewicz & Katarzyna Jagodzińska-Kalinowska
Article: P24
Published online: 04 Dec 2023
CitationforReimbursement categories as a way of allocating measures and monitoring expenditures on medicines | Full Text | PDF (423.9 KB)
  • 19 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
The effective and innovative cost saving of software in managing unregistered drugs
Nur Wahida Zulkifli, Noorizan Abd Aziz, Yahaya Hassan, Mohamed Azmi Hassali & Nur Liyana Zainal Bahrin
Article: P25
Published online: 04 Dec 2023
CitationforThe effective and innovative cost saving of software in managing unregistered drugs | Full Text | PDF (423.5 KB)
  • 19 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
Elizabeth Docteur, Joshua Cohen, Brian K Bruen, Ruth Lopert, Avi Dor & Chuck Shih
Article: P26
Published online: 04 Dec 2023
CitationforA framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate | Full Text | PDF (465.2 KB)
  • 19 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Medicines optimisation in Northern Ireland - scope and results of a challenging project
Mike Scott, Frans van Andel & Rob Brenninkmeijer
Article: P27
Published online: 04 Dec 2023
CitationforMedicines optimisation in Northern Ireland - scope and results of a challenging project | Full Text | PDF (421.4 KB)
  • 20 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Biosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines
Maarten Van Baelen
Article: P28
Published online: 04 Dec 2023
CitationforBiosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines | Full Text | References | PDF (528.2 KB)
  • 27 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Oration
Exploring the Impact of health-care cost sharing mechanisms in health service users for all the 27 member countries of the EU
Andreas Siakou & Costas Athanasakis
Article: P29
Published online: 04 Dec 2023
CitationforExploring the Impact of health-care cost sharing mechanisms in health service users for all the 27 member countries of the EU | Full Text | PDF (420.2 KB)
  • 16 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Precision medicine in pharmacy: assessing pharmacogenomics competence among pharmacists and pharmacy students
Mohanad Odeh et al.
Article | Published online: 10 Jun 2024
Open Access
Advancing opioid stewardship in low-middle-income countries: challenges and opportunities
Rojita Jadhari et al.
Article | Published online: 5 Jun 2024
Open Access
International comparison of availability for orphan drugs: focused on approved orphan drugs in South Korea
Eun Young Shin et al.
Article | Published online: 5 Jun 2024
Open Access
Impact of bevacizumab on clinical outcomes and its comparison with standard chemotherapy in metastatic colorectal cancer patients: a systematic review and meta-analysis
Tehnia Naz et al.
Article | Published online: 5 Jun 2024
Open Access